It provides information on the test gene, and provides detailed information to the log-in user.
| No. | Ingredient name | Drug classification | Main diseases | Genetic biomarkers |
|---|---|---|---|---|
| 161 | Allopurinol |
Gout medications | Gout, hyperuricemia, uric acid nephropathy | HLA-B |
| 162 | Metformin |
Antidiabetic drugs | Type 2 diabetes | C11orf65 |
| 163 | Gliclazide |
Antidiabetic drugs | Type 2 diabetes | CYP2C9 , KCNJ11 |
| 164 | Glibenclamide |
Antidiabetic drugs | Type 2 diabetes | CYP2C9 , G6PD , KCNJ11 |
| 165 | Glimepiride |
Antidiabetic drugs | Type 2 diabetes | CYP2C9 , G6PD , KCNJ11 |
| 166 | Warfarin |
Anticoagulants | Venous thrombosis, embolic atrial fibrillation, pulmonary embolism, coronary artery occlusion | CYP2C9 , VKORC1 , CYP4F2 |
| 167 | Fluorouracil |
Anticancer Drugs | Colon cancer, rectal cancer, esophageal cancer, stomach cancer, liver cancer, lung cancer, pancreatic cancer, gallbladder cancer, malignant cancer, tongue cancer, bladder cancer, kidney cancer, ovarian cancer, uterine cancer, skin cancer, eticulum cell sarcoma, Hodgkin s disease, lymphoma, fibrosarcoma | DPYD |
| 168 | Pazopanib |
Anticancer Drugs | Progressive renal cancer, progressive soft tissue sarcoma | UGT1A1 |
| 169 | Tamoxifen |
Anticancer Drugs | Breast cancer | CYP2D6 |
| 170 | Capecitabine |
Anticancer Drugs | Colon rectal cancer, breast cancer, stomach cancer | DPYD |
Drag left and right